Effects of Ginger Powder Supplementation on Glycemic Status and Lipid Profile in Patients with Type 2 Diabetes Mellitus

Not Applicable

• Conditions: Nutritional, Metabolic, Endocrine

• Registration Number: PACTR201807118168502
• Lead Sponsor: Faculty of Medicine, Ain Shams University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-08
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Newly diagnosed type 2 diabetes mellitus,
Glycated hemoglobin (HbA1c) level < 9%,
Body Mass Index (BMI) = 30 kg/ m2.

Exclusion Criteria

Diabetes duration more than 6 months,
HbA1c level = 9%,
BMI < 30 kg/ m2,
Insulin therapy,
Any injectable or oral antidiabetic medication other than metformin,
Any acute illnesses at baseline or during the study,
Smoking,
Consumption of less than 80% of the capsules,
Any sensitivity due to ginger consumption reported by the patient or noticed after the outset of the study,
Consumption of vitamin, mineral or other nutritional supplements,
Consumption of alcohol or narcotic drugs,
Pregnancy or lactation,
Any thyroid or autoimmune disorder,
Ischemic, cardiac or renal diseases,
Chronic inflammatory diseases,
Peptic ulcer,
Regular consumption of ginger or other herbal drugs,
Consumption of lipid lowering drugs or oral contraceptive pills.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood glucose, 2hour-postprandial blood glucose, Glycated hemoglobin, Total cholesterol, Triglycerides, Low density lipoprotein cholesterol, High density lipoprotein cholesterol

Secondary Outcome Measures

Name	Time	Method
Fasting insulin level, Homeostatic model assessment (HOMA2) indices: Insulin resistance (HOMA2 - IR), Insulin sensitivity (HOMA2 - %S), Beta-cell function (HOMA2 - %ß)